Construction and Validation of a Protocol Targeting Patients on Oral Anticoagulation with Warfarin.

IF 2 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Arquivos Brasileiros de Cardiologia Pub Date : 2023-06-01 DOI:10.36660/abc.20220576

Hannah Cardoso Barbosa, Heloisa de Carvalho Torres, João Antônio de Queiroz Oliveira, Rebeca Priscilla de Melo Santos, Josiane Moreira da Costa, Leonardo Gonçalves Miranda, Adriana Silvina Pagano, Marcus Fernando da Silva Praxedes, Maria Auxiliadora Parreiras Martins

{"title":"Construction and Validation of a Protocol Targeting Patients on Oral Anticoagulation with Warfarin.","authors":"Hannah Cardoso Barbosa, Heloisa de Carvalho Torres, João Antônio de Queiroz Oliveira, Rebeca Priscilla de Melo Santos, Josiane Moreira da Costa, Leonardo Gonçalves Miranda, Adriana Silvina Pagano, Marcus Fernando da Silva Praxedes, Maria Auxiliadora Parreiras Martins","doi":"10.36660/abc.20220576","DOIUrl":null,"url":null,"abstract":"Background: Warfarin is an oral anticoagulant that is very useful in preventing thromboembolism, though it is considered a drug with a high risk of causing adverse events. Considering the practical challenges in controlling oral anticoagulation, the patients on warfarin could benefit from educational strategies aimed at behavioral changes, active participation in self-care, and adherence to drug therapy.Objective: The aim was to construct and validate the EmpoderACO protocol for behavioral changes in warfarin patients.Methods: The methodological steps were: definition of concepts and domains of self-care, identification of objectives, construction and selection of items, assessment of content validity, and pre-test in the target population.Results: Relevance, adequacy, clarity, and internal reliability of the instrument's items were assessed by a multidisciplinary judges committee (JC) through the E-surv web platform, obtaining an average agreement of ≥0.91. The understanding of the instrument measured by the target population revealed adequate clarity with a coefficient average of 0.96.Conclusion: EmpoderACO can aid in qualifying the communication process between medical professionals and patients, as well as in improving adherence to both treatment and clinical outcomes, and can be replicated in healthcare settings.","PeriodicalId":8399,"journal":{"name":"Arquivos Brasileiros de Cardiologia","volume":"120 6","pages":"e20220576"},"PeriodicalIF":2.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344350/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arquivos Brasileiros de Cardiologia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.36660/abc.20220576","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Warfarin is an oral anticoagulant that is very useful in preventing thromboembolism, though it is considered a drug with a high risk of causing adverse events. Considering the practical challenges in controlling oral anticoagulation, the patients on warfarin could benefit from educational strategies aimed at behavioral changes, active participation in self-care, and adherence to drug therapy.

Objective: The aim was to construct and validate the EmpoderACO protocol for behavioral changes in warfarin patients.

Methods: The methodological steps were: definition of concepts and domains of self-care, identification of objectives, construction and selection of items, assessment of content validity, and pre-test in the target population.

Results: Relevance, adequacy, clarity, and internal reliability of the instrument's items were assessed by a multidisciplinary judges committee (JC) through the E-surv web platform, obtaining an average agreement of ≥0.91. The understanding of the instrument measured by the target population revealed adequate clarity with a coefficient average of 0.96.

Conclusion: EmpoderACO can aid in qualifying the communication process between medical professionals and patients, as well as in improving adherence to both treatment and clinical outcomes, and can be replicated in healthcare settings.

Abstract Image

查看原文本刊更多论文

构建并验证针对华法林口服抗凝药患者的方案。

背景：华法林是一种口服抗凝药，在预防血栓栓塞方面非常有用，但它被认为是一种极易引起不良反应的药物。考虑到控制口服抗凝药的实际困难，华法林患者可以从旨在改变行为、积极参与自我护理和坚持药物治疗的教育策略中获益：目的：构建并验证针对华法林患者行为改变的 EmpoderACO 方案：方法步骤包括：定义自我护理的概念和领域、确定目标、构建和选择项目、评估内容效度以及在目标人群中进行预测试：由一个多学科评委委员会（JC）通过 E-surv 网络平台对工具项目的相关性、适当性、清晰度和内部可靠性进行了评估，获得的平均一致性≥0.91。目标人群对该工具的理解程度显示出足够的清晰度，平均系数为 0.96：EmpoderACO 有助于改善医务人员与患者之间的沟通过程，提高患者对治疗和临床结果的依从性，可在医疗机构中推广使用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Arquivos Brasileiros de Cardiologia 医学-心血管系统

CiteScore

3.70

自引率

30.80%

发文量

234

审稿时长

3-8 weeks

期刊介绍： With more than 70 years of existence, Arquivos Brasileiros de Cardiologia is the main channel for the dissemination of Brazilian scientific research on cardiovascular sciences. Published in two languages and indexed in major international databases, all scientific contributions are peer-reviewed and reviewed by editorial board members selected among the most reputable researchers in Brazil and abroad. The manuscripts are reviewed according to their relevance and originality, scientific accuracy and level of importance for the advancement of science. With an average time of nine months between the initial submission and the effective publication of the manuscripts, and less than seven months until they are published on PubMed, Arquivos Brasileiros de Cardiologia can ensure the quick inclusion of the researchers’ papers in the international literature.